Join NBTS’s campaign to raise awareness about the importance of biomarker testing and clinical trials for patients with brain tumors.
READ MORE
For the sixth annual Glioblastoma Awareness Day, July 17, 2024, we gathered to raise nationwide awareness about glioblastoma (GBM), the most common, complex, treatment-resistant, and deadliest type of brain cancer. National Brain Tumor Society spearheaded this annual event in 2019 to support survivors and their loved ones, to remember those who are no longer with us, and to honor luminaries working toward a cure and better quality of life for those living with this devastating disease.
We invite you to watch our video program amplifying the voices of patients and care partners impacted by glioblastoma. Hear their experiences, what “a better chance” means to them, and why breakthroughs can’t wait.
received a glioblastoma diagnosis in 2023
is the five-year survival rate for glioblastoma patients
will succumb to glioblastoma this year
have been approved by the FDA — and one device — for glioblastoma
Share your story, amplify key information about glioblastoma, and inspire others to take action.
You are not alone. Read stories about the shared challenges and hopes of people affected by glioblastoma, including patients, caregivers, and loved ones, and watch messages of support. Here, you’ll also find news stories and research updates about glioblastoma.
Thank you for your essential role in fueling research and treatments for glioblastoma.
